SCHEMBL19985159

SCHEMBL19985159

N#COc1ccc(N2Cc3ccc(O)cc3OC2=O)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MIF P14174 8/20 0.61
HDAC3 O15379 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC2 Q92769 1/20 0.44
MAPKAPK2 P49137 1/20 0.36
HSD17B3 P37058 1/20 0.36
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
KIT P10721 1/20 0.32
ESR1 P03372 2/20 0.32
DRD4 P21917 1/20 0.31
DRD5 P21918 1/20 0.31
DRD3 P35462 1/20 0.31
ELANE P08246 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
ALOX15 P16050 1/20 0.31
ALOX12 P18054 1/20 0.31
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2765998 0.86 MIF (0.70) MIFHDAC3HDAC1HDAC2NPC1
SCHEMBL2766991 0.85 MIF (0.74) MIFHDAC3HDAC1HDAC2HSD17B3
SCHEMBL2766883 0.82 MIF (0.60) MIFHDAC3HDAC1HDAC2MAPKAPK2
SCHEMBL2766942 0.82 MIF (0.60) MIFHDAC3HDAC1HDAC2HSD17B3
SCHEMBL3551113 0.81 MIF (0.58) MIFHDAC3HDAC1HDAC2HSD17B3
SCHEMBL26938963 0.81 MIF (0.67) MIFHDAC3HDAC1HDAC2HSD17B3
SCHEMBL2765855 0.80 MIF (0.63) MIFHDAC3HDAC1HDAC2NPC1
SCHEMBL3547917 0.80 MIF (0.67) MIFHDAC3HDAC1HDAC2HSD17B3
SCHEMBL24398658 0.79 MIF (0.62) MIFHDAC3HDAC1HDAC2HSD17B3
SCHEMBL2766423 0.79 MIF (0.59) MIFHDAC3HDAC1HDAC2HSD17B3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2944310-B1 MIF inhibitors for the acute or chronic treatment of pulmonary hypertension MIFCARE (FR) 2018-03-21 EP disclosed